Ctni Ck Mb Myo Lab Test
video

Ctni Ck Mb Myo Lab Test

Description The combination detection of cTnI, CK-MB, and myo markers is a valuable tool for the accurate and timely diagnosis of myocardial infarction patients. This lab test offers a sensitive, specific, and speedy diagnosis that can lead to early intervention and treatment, ultimately...
Send Inquiry
Product Introduction

Description

The combination detection of cTnI, CK-MB, and myo markers is a valuable tool for the accurate and timely diagnosis of myocardial infarction patients. This lab test offers a sensitive, specific, and speedy diagnosis that can lead to early intervention and treatment, ultimately lowering the risk of missed diagnoses.
The Ctni Ck Mb Myo Lab Test is applicable for quantifying the concentration of these markers in human serum, plasma, or whole blood, making it a versatile solution for clinical diagnosis, prognosis, and evaluation of myocardial injury diseases such as acute myocardial infarction, unstable angina, acute myocarditis, and acute coronary syndrome.
By leveraging this powerful diagnostic tool, medical professionals can increase their accuracy in identifying and treating patients with heart related concerns. The results of this test can provide valuable insights into the overall health of a patient's heart and guide clinicians in developing personalized treatment plans that are tailored to the specific needs of the individual.

Principle
The Ctni Ck Mb Myo Lab Test utilizes the immunochromatographic assay principle to measure the concentration of cTnI/CK-MB/MYO in human serum, plasma, or whole blood. This is achieved through a double antibody sandwich method. The test card remains stable for 18 months when sealed in an aluminum foil bag and stored within a temperature range of 2~30 °C. It is crucial to note that once the test card bag is opened, the test must be conducted within 1 hour. Please refer to the packaging or label for the production date.

Product information

Product name

Sample type

Specification

Ctni ck mb myo lab test kit

Serum, plasma or whole blood

25 tests/kit


Applied instrument
Shenzhen Ultra-Popular Biotec. Co., Ltd. presents the UP-F1000 Dry-type Immunofluorescence Quantitative Analyzer. This advanced technology is an epitome of innovation and precision, designed to cater to the requirements of modern diagnostics. The device is equipped with an efficient dry-type immunofluorescence technique that provides reliable and accurate results. The analyzer is perfect for qPCR and gene amplification due to its high sensitivity and specificity. It can also easily incorporate artificial intelligence technology to enhance its capabilities further. So, if you're looking for a dependable and efficient device for your laboratory, the UP-F1000 is the way to go!


Index of characteristics
1. The Lowest Detection Limit:
CK-MB less than 2.5 ng/mL;
cTnI less than 0.1 ng/mL;
Myo less than 30.0 ng/mL.
2. Measuring Range:
CK-MB 2.5-100.0 ng/mL;The correlation coefficient (R) is >0.99.;
cTnI 0.1-50.0 ng/mL,The correlation coefficient (R) is >0.99.;
Myo 30.0-500.0 ng/mL,The correlation coefficient (R) is >0.99.;
3. Within-run Precision:CV≤15%;
4. Between-run Precision:CV≤15%;
5. Accuracy:
To test the control materials for CK-MB, the acceptable range for the relative deviation is ±15.0%. It is crucial to adhere to this range in order to ensure accurate and reliable results.
The control materials of cTnI must undergo testing to ensure that the relative deviation falls within the range of ±15.0%. It is important to maintain consistency in the results of these tests to ensure accurate and reliable results.
To assess the control materials of Myo, it is crucial to ensure that the relative deviation falls within the range of ±15.0%. Producing a closely resembling content, please reorganize the information mentioned above while maintaining the original text's essence.

Hot Tags: ctni ck mb myo lab test, China ctni ck mb myo lab test manufacturers, suppliers, factory

Send Inquiry